New York State Teachers Retirement System (NYSTRS)’s PTC Therapeutics PTCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.64M Sell
44,637
-316
-0.7% -$22.8K 0.01% 922
2026
Q1
$3.06M Buy
44,953
+316
+0.7% +$22.4K 0.01% 944
2025
Q4
$3.39M Buy
+44,637
New +$3.24M 0.01% 933

Other funds holding PTCT

New York State Teachers Retirement System (NYSTRS)'s PTCT Position: Q2 2026 in Review

New York State Teachers Retirement System (NYSTRS) reduced its PTC Therapeutics (PTCT) stake by 0.7% in Q2 2026, selling an estimated $22.8K and leaving 44,637 shares worth $3.64M. The position accounts for 0.01% of the portfolio, ranked #922.

New York State Teachers Retirement System (NYSTRS) first reported a position in PTCT in Q4 2025 and has held it in 3 quarters since. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • New York State Teachers Retirement System (NYSTRS) held 44,637 shares of PTC Therapeutics worth $3.64M as of Q2 2026.
  • New York State Teachers Retirement System (NYSTRS) sold 316 PTC Therapeutics shares in Q2 2026, an estimated $22.8K.
  • PTC Therapeutics made up 0.01% of New York State Teachers Retirement System (NYSTRS)'s portfolio in Q2 2026, its #922 holding.
  • New York State Teachers Retirement System (NYSTRS) first reported a position in PTC Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on New York State Teachers Retirement System (NYSTRS)'s 13F filing for Q2 2026, filed 23 Jul 2026.